Literature DB >> 8538652

Identification of a damaged-DNA binding domain of the XPA protein.

I Kuraoka1, E H Morita, M Saijo, T Matsuda, K Morikawa, M Shirakawa, K Tanaka.   

Abstract

The XPA (xeroderma pigmentosum group A) protein is a zinc metalloprotein consisting of 273 amino acids which binds preferentially to UV- or chemical carcinogen-damaged DNA, suggesting that it is involved in the recognition of several types of DNA damage during nucleotide excision repair processes. Here we identify a DNA binding domain of the XPA protein. The region of the XPA protein responsible for preferential binding to DNA damaged by UV or cis-diammine-dichloroplatinum(II) (cisplatin) is contained within a truncated derivative of the XPA protein, MF122, consisting of 122 amino acids and containing a C4 type zinc finger motif. CD (circular dichroism) measurements of the MF122 protein showed that it has a helix-rich secondary structure, suggesting that it is a discretely folded, functional mini-domain. The MF122 protein should be useful for structural investigation of the XPA protein and of its interaction with damaged DNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8538652     DOI: 10.1016/0921-8777(95)00038-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  27 in total

1.  Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin.

Authors:  F Carrier; P T Georgel; P Pourquier; M Blake; H U Kontny; M J Antinore; M Gariboldi; T G Myers; J N Weinstein; Y Pommier; A J Fornace
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Nucleotide excision repair by mutant xeroderma pigmentosum group A (XPA) proteins with deficiency in interaction with RPA.

Authors:  Masafumi Saijo; Arato Takedachi; Kiyoji Tanaka
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

3.  The C-terminal zinc finger of UvrA does not bind DNA directly but regulates damage-specific DNA binding.

Authors:  Deborah L Croteau; Matthew J DellaVecchia; Hong Wang; Rachelle J Bienstock; Mark A Melton; Bennett Van Houten
Journal:  J Biol Chem       Date:  2006-07-07       Impact factor: 5.157

4.  Domains in the XPA protein important in its role as a processivity factor.

Authors:  Claudine L Bartels; Muriel W Lambert
Journal:  Biochem Biophys Res Commun       Date:  2007-03-02       Impact factor: 3.575

5.  Photocrosslinking locates a binding site for the large subunit of human replication protein A to the damaged strand of cisplatin-modified DNA.

Authors:  U Schweizer; T Hey; G Lipps; G Krauss
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

6.  Assembly, subunit composition, and footprint of human DNA repair excision nuclease.

Authors:  M Wakasugi; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

7.  Human nucleotide excision repair protein XPA: expression and NMR backbone assignments of the 14.7 kDa minimal damaged DNA binding domain (Met98-Phe219).

Authors:  G W Buchko; S Ni; B D Thrall; M A Kennedy
Journal:  J Biomol NMR       Date:  1997-10       Impact factor: 2.835

8.  Structural insights into the recognition of cisplatin and AAF-dG lesion by Rad14 (XPA).

Authors:  Sandra C Koch; Jochen Kuper; Karola L Gasteiger; Nina Simon; Ralf Strasser; David Eisen; Simon Geiger; Sabine Schneider; Caroline Kisker; Thomas Carell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

Review 9.  Orchestral maneuvers at the damaged sites in nucleotide excision repair.

Authors:  Sergey Alekseev; Frédéric Coin
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

10.  Analysis of DNA binding by human factor xeroderma pigmentosum complementation group A (XPA) provides insight into its interactions with nucleotide excision repair substrates.

Authors:  Norie Sugitani; Markus W Voehler; Michelle S Roh; Agnieszka M Topolska-Woś; Walter J Chazin
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.